Board of Directors
John Presutti, MBA – Chairman of the Board
In over 30 years in the pharmaceutical business, Mr. Presutti has served as a financial, marketing, and business development executive at GD Searle and managed commercial activities for Curatek Pharmaceuticals. Most recently he started and ultimately divested Presutti Laboratories after successfully bringing an antibacterial agent to the US Market. He has successfully taken drugs through the regulatory and commercialization process, both for large pharma and as an independent entrepreneur. Mr. Presutti was a founding member of the Board of Directors.
Tibor Papp, MD, PhD, MBA – Director
Dr. Papp is currently a Senior Director of Business Development at Shire Pharmaceuticals with global responsibility for generating deals in the therapy areas of hematology-oncology, transplantation and complement-mediated diseases. With 24 years of healthcare, 14 years of pharmaceutical industry, and 10 years of business development experience, Dr. Papp brings substantial expertise to the board of PharmaIN. He has helped global pharma and biotechnology companies develop and adjust their product development and market strategies, and supported them in doing licensing and M&A deals. Dr. Papp is also a qualified orthopedic surgeon, with a PhD from the University of Aberdeen and an MBA from the University of Oxford.
Yuriy Rubin, CFA, MBA – Director
Mr. Rubin is a globally experienced investor and presently is Deputy CEO of Investments and Finance at Irkutsk Oil Company. Previous positions have included Financial Advisor at Prudential Securities and Merrill Lynch. Mr. Rubin holds an MBA from Moscow Russian-American University and a BS in Software Engineering from the University of Radio Engineering and Electronics of Moscow.
Lester Salans, MD – Director
Dr. Salans is an internationally recognized expert in the fields of diabetes mellitus, obesity, and endocrinology. He has broad and extensive experience in biomedical research, clinical medicine, and administration in the pharmaceutical industry, academia, and in government. Dr. Salans received his M.D. from the University of Illinois, College of Medicine, followed by internship and residency in internal medicine at Stanford University Medical Center and The Rockefeller University. Previously he has served as VP, Scientific and Academic Affairs and Deputy President for the Sandoz Research Institute, and was Director of the National Institute of Diabetes, Digestive Diseases and Kidney Diseases (NIDDK), NIH. Currently he is Clinical Professor and member of the Clinical Staff at Mt. Sinai, Adjunct Professor of Medicine, Columbia University Medical Center, and serves on the board of Forest Laboratories, Inc.
Elijah Bolotin, PhD – Founder, President, CEO and member of the Board of Directors
Dr. Bolotin has nearly 20 years in drug delivery, drug development and management. Prior to PharmaIN, Dr. Bolotin was Group Leader, Drug Delivery, and Technical Leader for New Technology Evaluation at Endorex Corp. (IL), and a research scientist at the NYU Medical Center (NY) and the All Union Cardio Center (Moscow). Dr. Bolotin received his PhD from The Hebrew University, Israel in biochemistry and pharmaceuticals.
Gerry Castillo, PhD – Director of Research and Intellectual Property
Dr. Castillo has over 20 years experience in clinical and analytical biochemistry. Dr. Castillo is author to numerous manuscripts and presentations. Prior to PharmaIN, Dr. Castillo was Director of Biochemistry, ProteoTech, Inc. Dr. Castillo is a registered patent agent, and holder of over 40 patents. He received his BS, Biochemistry with honors from University of Saskatchewan, Canada, an MS in Clinical Chemistry from the University of Windsor, and his PhD, in Clinical Biochemistry from the University of Toronto, Canada.
Joshua Alfaro, PhD – Director of CMC and QA
Joshua has a broad chemistry background ranging from organic synthesis to methods development for the analysis of protein post-translation modifications and copolymers. He has over 11 years combined experience after receiving his PhD at Washington State University (WSU) in organic chemistry. Joshua worked as a postdoctoral researcher for 5 years at WSU and Pacific Northwest National Laboratory (PNNL), and as a scientist in the biotech/pharma industry for the past 6 years; he worked at Ezose Sciences Inc. prior to joining the PharmaIN team in April 2014.
Mark Edelsward – Director of Business Development
Mark has over 20 years of experience in technology sales leadership. Prior to PharmaIN, Mark was Vice President of WW Sales and Marketing at Data I/O Corp, Director of OEM Technology Sales at Microsoft and Vice President of International Sales at Listen Inc.